Cargando…

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy

The emergence and establishment of SARS-CoV-2 variants of interest (VOI) and variants of concern (VOC) highlight the importance of genomic surveillance. We propose a statistical learning strategy (SLS) for identifying and spatiotemporally tracking potentially relevant Spike protein mutations. We ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lue Ping, Lybrand, Terry P., Gilbert, Peter B., Hawn, Thomas R., Schiffer, Joshua T., Stamatatos, Leonidas, Payne, Thomas H., Carpp, Lindsay N., Geraghty, Daniel E., Jerome, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219100/
https://www.ncbi.nlm.nih.gov/pubmed/34159336
http://dx.doi.org/10.1101/2021.06.15.448495
_version_ 1783710862531362816
author Zhao, Lue Ping
Lybrand, Terry P.
Gilbert, Peter B.
Hawn, Thomas R.
Schiffer, Joshua T.
Stamatatos, Leonidas
Payne, Thomas H.
Carpp, Lindsay N.
Geraghty, Daniel E.
Jerome, Keith R.
author_facet Zhao, Lue Ping
Lybrand, Terry P.
Gilbert, Peter B.
Hawn, Thomas R.
Schiffer, Joshua T.
Stamatatos, Leonidas
Payne, Thomas H.
Carpp, Lindsay N.
Geraghty, Daniel E.
Jerome, Keith R.
author_sort Zhao, Lue Ping
collection PubMed
description The emergence and establishment of SARS-CoV-2 variants of interest (VOI) and variants of concern (VOC) highlight the importance of genomic surveillance. We propose a statistical learning strategy (SLS) for identifying and spatiotemporally tracking potentially relevant Spike protein mutations. We analyzed 167,893 Spike protein sequences from US COVID-19 cases (excluding 21,391 sequences from VOI/VOC strains) deposited at GISAID from January 19, 2020 to March 15, 2021. Alignment against the reference Spike protein sequence led to the identification of viral residue variants (VRVs), i.e., residues harboring a substitution compared to the reference strain. Next, generalized additive models were applied to model VRV temporal dynamics, to identify VRVs with significant and substantial dynamics (false discovery rate q-value <0.01; maximum VRV proportion > 10% on at least one day). Unsupervised learning was then applied to hierarchically organize VRVs by spatiotemporal patterns and identify VRV-haplotypes. Finally, homology modelling was performed to gain insight into potential impact of VRVs on Spike protein structure. We identified 90 VRVs, 71 of which have not previously been observed in a VOI/VOC, and 35 of which have emerged recently and are durably present. Our analysis identifies 17 VRVs ~91 days earlier than their first corresponding VOI/VOC publication. Unsupervised learning revealed eight VRV-haplotypes of 4 VRVs or more, suggesting two emerging strains (B1.1.222 and B.1.234). Structural modeling supported potential functional impact of the D1118H and L452R mutations. The SLS approach equally monitors all Spike residues over time, independently of existing phylogenic classifications, and is complementary to existing genomic surveillance methods.
format Online
Article
Text
id pubmed-8219100
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-82191002021-06-23 Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy Zhao, Lue Ping Lybrand, Terry P. Gilbert, Peter B. Hawn, Thomas R. Schiffer, Joshua T. Stamatatos, Leonidas Payne, Thomas H. Carpp, Lindsay N. Geraghty, Daniel E. Jerome, Keith R. bioRxiv Article The emergence and establishment of SARS-CoV-2 variants of interest (VOI) and variants of concern (VOC) highlight the importance of genomic surveillance. We propose a statistical learning strategy (SLS) for identifying and spatiotemporally tracking potentially relevant Spike protein mutations. We analyzed 167,893 Spike protein sequences from US COVID-19 cases (excluding 21,391 sequences from VOI/VOC strains) deposited at GISAID from January 19, 2020 to March 15, 2021. Alignment against the reference Spike protein sequence led to the identification of viral residue variants (VRVs), i.e., residues harboring a substitution compared to the reference strain. Next, generalized additive models were applied to model VRV temporal dynamics, to identify VRVs with significant and substantial dynamics (false discovery rate q-value <0.01; maximum VRV proportion > 10% on at least one day). Unsupervised learning was then applied to hierarchically organize VRVs by spatiotemporal patterns and identify VRV-haplotypes. Finally, homology modelling was performed to gain insight into potential impact of VRVs on Spike protein structure. We identified 90 VRVs, 71 of which have not previously been observed in a VOI/VOC, and 35 of which have emerged recently and are durably present. Our analysis identifies 17 VRVs ~91 days earlier than their first corresponding VOI/VOC publication. Unsupervised learning revealed eight VRV-haplotypes of 4 VRVs or more, suggesting two emerging strains (B1.1.222 and B.1.234). Structural modeling supported potential functional impact of the D1118H and L452R mutations. The SLS approach equally monitors all Spike residues over time, independently of existing phylogenic classifications, and is complementary to existing genomic surveillance methods. Cold Spring Harbor Laboratory 2021-06-15 /pmc/articles/PMC8219100/ /pubmed/34159336 http://dx.doi.org/10.1101/2021.06.15.448495 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Zhao, Lue Ping
Lybrand, Terry P.
Gilbert, Peter B.
Hawn, Thomas R.
Schiffer, Joshua T.
Stamatatos, Leonidas
Payne, Thomas H.
Carpp, Lindsay N.
Geraghty, Daniel E.
Jerome, Keith R.
Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title_full Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title_fullStr Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title_full_unstemmed Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title_short Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy
title_sort tracking sars-cov-2 spike protein mutations in the united states (2020/01 – 2021/03) using a statistical learning strategy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219100/
https://www.ncbi.nlm.nih.gov/pubmed/34159336
http://dx.doi.org/10.1101/2021.06.15.448495
work_keys_str_mv AT zhaolueping trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT lybrandterryp trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT gilbertpeterb trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT hawnthomasr trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT schifferjoshuat trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT stamatatosleonidas trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT paynethomash trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT carpplindsayn trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT geraghtydaniele trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy
AT jeromekeithr trackingsarscov2spikeproteinmutationsintheunitedstates202001202103usingastatisticallearningstrategy